Elixxer Ltd. (ELIXF)
OTCMKTS · Delayed Price · Currency is USD
0.0335
+0.0223 (199.11%)
At close: Jan 22, 2026
Elixxer Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.19M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medical Marijuana | 58.98M |
| Trees | 14.50M |
| CordovaCann | 9.83M |
| SOHM, Inc. | 1.30M |
| For The Earth | 687.89K |
| Rafarma Pharmaceuticals | 133.33K |
| Cannabis Bioscience International Holdings | 123.63K |
| Indo Global Exchange(s) PTE | 3.49K |